Roper Technologies Research from a Long-Term Owner's Perspective

Inference: From the perspective of a long-term business owner, Roper is essentially a “decentralized capital-allocation platform that owns sticky vertical software assets and a small number of high-value technology-product assets.” The model is not mysterious. The hard part is that you are not analyzing a single-product company, but a portfolio of small, deep, category-leading businesses, plus the question of where headquarters reallocates cash flow. In other words, the underlying businesses are understandable, while group-level capital allocation is more important.

Who are the customers, how are they charged, and is revenue stable? Fact: Customers span law firms, laboratories, hospitals, schools, insurance distribution chains, construction contractors, freight participants, pharmacies, water utilities, hospitals, businesses, and government-related entities. In 2025, no single customer accounted for more than 10% of any segment’s revenue or total revenue. At the same time, the company also notes that some businesses have exposure to large customers or government projects.

Fact: Business “predictability” comes from several layers:

• Remaining performance obligations in 2025 were $5.204 billion, up from $4.755 billion in 2024; backlog expected to be recognized over the next 12 months was $3.425 billion.

• Net contract liabilities at year-end 2025 were negative $1.954 billion, mainly due to deferred revenue, reflecting customer prepayment characteristics.

• Payment terms for software and related services are usually 30 to 60 days; SaaS and maintenance revenue is mostly recognized over the contract term.

Fact: The cost structure is very strong. In 2025, total gross margin was 69.2%, with segment gross margins of 68.5% for Application Software, 84.1% for Network Software, and 58.1% for Technology Enabled Products; total operating margin was 28.3%. R&D and engineering expense in 2025 was $853 million, but this is expensed within SG&A and is not the cost structure of a typical heavy-asset manufacturer. The company also explicitly says future capital expenditures plus capitalized software expenditures usually total only 1.0% to 1.5% of revenue.

Fact: On the supply side, the company believes most raw materials and supplies can be obtained from numerous sources, although some components and subassemblies still come from a limited number of suppliers. On channels, sales are conducted through direct sales, representatives, resellers, and distributors. Technology product businesses are affected by regulations such as FDA, HIPAA, GDPR, and CCPA, while software businesses remain subject to data privacy and cybersecurity regulations.

Opinion: If the stock market closed for five years, I would be willing to own this business, but only if the position were not built on the optimistic assumption that “it will definitely keep making high-premium acquisitions.” The reason is straightforward: the underlying asset quality is good, repeat revenue is solid, and cash flow is strong; but group-level capital allocation has a major impact on long-term results. It is therefore more like a combination of “excellent business + excellent capital-allocation team,” rather than an ironclad consumer stock that does not require management to keep making the right decisions.

Industry and competitive-structure score: 4/5.

Fact: Roper publicly discloses that its products and solutions generally face significant competition, although the number of competitors is limited in certain niche markets. The company believes it holds leading positions in most of its markets, and no single competitor comprehensively overlaps with it across a large number of product lines. The main dimensions of competition are product quality, performance, innovation, technology, price, application expertise, flexibility of systems and services, channels, and customer-service capability.

Inference: This is not a “single industry,” but a portfolio of vertical-industry software, network marketplaces, and technology-product subindustries. Most of these subindustries are in mature but sustainably growing stages, rather than early explosive growth or sunset decline: legal software, education software, laboratory software, insurance software, freight matching, payments and identity management, pharmacy software, water metering, and hospital equipment all serve needs that persist over the long term, face relatively slow replacement cycles, and have high customer migration costs. For that reason, Roper is more like “a collection of good companies in good industries,” rather than “an outstanding company in a poor industry.”

Fact: Several pieces of evidence disclosed on the company website illustrate competitive position and stickiness well: Aderant serves 3,200 customers and covers 77 of the global top 100 law firms, with gross customer retention above 95%; Frontline covers more than 10,000 K-12 customers; Vertafore serves more than 20,000 agencies, more than 1,000 insurance carriers, and 23 state governments; Data Innovations serves more than 6,000 hospitals and laboratories across more than 85 countries; Illumia serves more than 10,000 higher-education, healthcare, and senior-living institutions.

Fact: Roper is not completely non-cyclical. In July 2024, the company issued a softer outlook because enterprise software spending was weak and contracts were delayed; by October 2024, as demand improved and acquisitions contributed, the company raised full-year guidance. This shows resilience against cycles, but not immunity.

Moat Assessment

Moat strength score: 4/5. Overall judgment: stable with a bias toward expansion.

Brand advantage Inference: Roper’s brand moat is mainly not in the “Roper” group name, but in its vertical software brands and industry positions. Aderant, Vertafore, Frontline, Deltek, DAT, ConstructConnect, Clinisys, and Data Innovations, for example, are professional brands long used by industry customers at their respective workflow nodes. This is therefore a “distributed brand” moat, not a consumer-goods parent-brand moat.

Cost advantage and scale advantage Fact: Roper’s operating margin has remained high over the long term, at 28.2%, 28.4%, and 28.3% from 2023 to 2025, respectively, and about 28.1% on a TTM basis; Network Software gross margin reached 84.1% in 2025. The company expects future capital expenditures plus capitalized software expenditures to total only 1.0% to 1.5% of revenue. This shows that many of its businesses have strongly asset-light characteristics.

Inference: Roper’s “cost advantage” is not low-price competition, but a compound advantage from high gross margins, low capital intensity, narrow vertical focus, limited headquarters expense, and shared capital and management frameworks after acquisitions. It may not be the lowest-cost player in every product line, but it has a major advantage at the level of “operating cash flow / capital invested.”

Network effects Fact: Not all businesses have network effects, but some Network Software businesses clearly have platform and network characteristics. DAT, for example, is North America’s largest spot freight matching network; iTradeNetwork is a SaaS transaction network for the food industry; ConstructConnect links general contractors, subcontractors, building-material participants, designers, and owners; iPipeline connects insurance carriers, brokers, and adviser networks.

Switching costs Fact: Many of Roper’s software products are embedded deep in customers’ daily workflows, compliance processes, billing, clinical operations, identity authentication, payments, campus management, laboratory management, and agent/channel collaboration. Aderant retention is above 95%, and businesses such as Vertafore, Frontline, Illumia, and Data Innovations are embedded in customers’ core processes.

Inference: Once these products are deployed, replacement is not merely a software migration issue. It also involves user habits, data structures, historical records, regulatory compliance, interface ecosystems, and downtime risk. Therefore, Roper’s core moat is essentially high switching costs + deep workflow embedding. This matters more than a “patent barrier.”

Channel advantages, regulatory advantages, and data advantages Fact: Some of the company’s businesses operate in heavily regulated fields, such as medical devices, healthcare data, privacy and cross-border data, insurance compliance, and campus payments. At the same time, businesses such as Vertafore, iPipeline, DAT, ConstructConnect, Strata, and Data Innovations have accumulated large amounts of domain data and industry connectivity. In its 10-K, the company explicitly states that its AI capabilities are using deep domain expertise, proprietary data, and long-standing customer relationships to enhance product differentiation and expand automation and monetization opportunities.

Patents and licenses Fact: The company owns or licenses a large amount of intellectual property, including patents, trademarks, copyrights, and source code, but it also clearly states that its operating units are not “materially dependent on any single intellectual property right.” In other words, patents are an auxiliary barrier, not the core moat.

Culture, operating capability, and capital-allocation capability Fact: The company uses a decentralized operating model, with each business unit independently responsible for day-to-day operating decisions; headquarters emphasizes operational improvement and capital allocation. Over the past three years, the company has deployed about $8.96 billion for acquisitions. From 2023 to 2025, the company completed a series of large acquisitions including Syntellis, Procare, Transact, CentralReach, and Subsplash.

Opinion: Roper’s deepest moat may not be any single product, but the organizational capability to “select high-quality niche assets, hold them, improve cash flow, and redeploy capital.” If that moat remains effective, it can widen over time; if acquisition discipline deteriorates, it can also become a source of risk.

Is the moat widening, stable, or narrowing? My judgment: stable with a bias toward expansion. The evidence lies in two points: first, both the software share and high-repeat revenue share are rising; second, the company repeatedly emphasizes that AI product launches are built on proprietary data and deep workflows, rather than isolated wrappers around general-purpose models. As long as this judgment holds, AI is more likely to reinforce its industry embedding than weaken it.

Can it raise prices in inflationary environments and remain profitable in downturns? Inference: Most likely yes, but pricing power is uneven. Software, data, transaction-fee, and workflow products are easier to reprice than technology products. In 2025, total organic growth was 5.4%, and segment operating margins remained generally high. Even though enterprise spending weakened and contracts were delayed in 2024, the company remained profitable and restored guidance during the year. This shows strong earnings resilience, though not complete immunity to macro conditions.

Management and Capital Allocation

Management and capital-allocation score: 4/5.

Honest, rational, and long-term oriented? Fact: In the 2026 proxy statement, the board repeatedly emphasized “long-term value creation, asset-light businesses, durable free cash flow, and patient capital deployment,” and treated high-quality acquisitions and compounding free cash flow per share as the core framework. In 2025, 96% of the CEO’s target direct compensation and an average of 91% of other executives’ target direct compensation were tied to share price and performance goals; Roper also has explicit executive stock ownership requirements and three-year vesting requirements. In the 2026 advisory vote on executive compensation, votes in favor totaled 83.849 million shares, while votes against totaled 5.263 million shares.

But the other side also matters. Fact: The 2026 proxy materials show that all current directors and named executive officers together owned 819,657 shares, representing less than 1% ownership. This means management’s economic alignment depends more on compensation incentives and options than on very high “real-money” long-term ownership. From a Buffett-style perspective, this is not a major problem, but it is certainly not a perfect score.

Has past capital allocation been excellent? Fact: From 2023 to 2025, the company deployed about $8.96 billion cumulatively for acquisitions; in 2025 it acquired CentralReach for about $1.85 billion and Subsplash for about $800 million; in 2024 it acquired Procare for about $1.86 billion and Transact for about $1.6 billion; in 2023 it acquired Syntellis for about $1.38 billion. Meanwhile, in 2022 the company completed the sale of a majority interest in Indicor while retaining a minority interest, further divesting assets that were historically more industrial.

Inference: The strategic direction is very clear: sell more capital-intensive and more cyclical industrial assets, and shift the portfolio decisively toward software, data, workflows, and sticky technology products. Directionally, this is correct and shareholder-friendly. The question is not the direction, but whether the company can keep replicating historical success at good prices.

How does the company use cash? Fact: In 2025, operating cash flow was $2.540 billion; capital expenditures were $47.4 million, capitalized software expenditures were $57.3 million; dividends were $355 million; and Q4 repurchases were $500 million. In Q1 2026, the company repurchased another $1.500 billion at an average price of about $350.99; from April 1 to April 30, it continued repurchasing $528.4 million at an average price of about $352.87. After Q1 2026, the board added another $3.0 billion repurchase authorization, lifting remaining capacity to $3.8 billion.

Opinion: At the current stage, Roper’s cash-deployment priorities are roughly: high-quality acquisitions > opportunistic repurchases > steadily rising dividends > preserving investment-grade debt flexibility. This is consistent with its historical behavior and fits the typical pattern of a “compounder capital allocator.”

Are repurchases rational? Fact: In Q4 2025, the company repurchased shares at about $445.87 per share; in Q1 2026 and April, the average repurchase price was around $351 to $353, while the current price is about $326.94. At least in hindsight, repurchases since 2026 have been closer to “buying during valuation compression,” rather than pure EPS optics; but Q4 2025 repurchases above $445 do not look cheap now.

Do acquisitions create value? Fact: Public disclosures do not allow us to directly calculate the long-term IRR of each acquisition or separate the true capital return of individual deals. What can be confirmed is that from 2023 to 2025, revenue, operating profit, and free cash flow all rose, while the software revenue share continued to increase. On the other hand, Roper also explicitly warns in its 10-K that growth depends heavily on acquisitions and carries risks of selecting the wrong targets, failed integration, overpaying, and failing to realize expected revenue and cash flow.

Is equity compensation reasonable? Is dilution excessive? Fact: The average burn rate over the past three years was 0.66%, below the 2.15% industry benchmark used by proxy advisers; as of March 23, 2026, overhang was 4.93%. But the same proxy materials also show that the company requested an additional 14.15 million shares under the 2021 incentive plan, equal to about 13.8% of shares outstanding at that time; shareholders ultimately approved the proposal in 2026.

Opinion: My judgment is that historically, incentives have not been aggressive, but the latest authorization is large and requires vigilance. Therefore, I give management and capital allocation a high score, but not a perfect score.

Financial Quality and Owner Earnings

Financial quality score: High, but one must distinguish “core operating performance” from “acquisition-accounting noise.”

The table below organizes key data using the lens that matters most to long-term owners. All figures except per-share figures are in millions of U.S. dollars. “Adjusted free cash flow” uses the company’s framework that is closer to an operating perspective, namely operating cash flow - capital expenditures - capitalized software expenditures. GAAP net income in 2022 is distorted by the Indicor divestiture and discontinued operations, so in the body text I focus more on the sustainable trend after 2023.

Data note: 2021-2025 and TTM data come from StockAnalysis/Fiscal.ai aggregates that point to original SEC filings; 2025 and Q1 2026 core cash flow, capital expenditures, debt, and share data have been cross-checked against the company’s 10-K/10-Q.

Fact: From 2021 to 2025, revenue grew from $4.834 billion to $7.903 billion; operating profit grew from $1.241 billion to $2.235 billion; operating margin from 2023 to 2025 was essentially stable around 28%. More importantly, adjusted free cash flow rose from about $1.927 billion to $2.466 billion from 2023 to 2025, showing that growth was not achieved by “burning more capital.”

Fact: Free-cash-flow conversion is meaningfully better than net income. In 2025, GAAP operating cash flow was $2.540 billion, and GAAP net income was $1.536 billion; even under the company’s more conservative “adjusted free cash flow” framework, the figure was $2.466 billion, clearly above net income. Deferred revenue, prepayment characteristics, and negative working capital are important reasons: at year-end 2025, net working capital excluding cash and debt was negative $1.390 billion; net contract liabilities at year-end 2025 were about $1.954 billion. This shows that a significant portion of earnings is real cash, not merely accounting revenue.

Fact: Capital intensity is very low. In 2025, capital expenditures plus capitalized software expenditures totaled about $105 million, or about 1.3% of revenue; the company itself also expects the future total to be only 1.0% to 1.5% of revenue. This is critical for long-term owners because it means most operating cash flow can be used for acquisitions, repurchases, dividends, or debt repayment, rather than being continuously swallowed by plants and equipment.

Fact: The balance sheet is not without issues. At the end of Q1 2026, total debt was $10.464 billion and net debt was $10.081 billion; using TTM EBITDA of about $3.207 billion, net debt/EBITDA is about 3.1x. In 2025, operating profit was $2.235 billion and net interest expense was $325 million, implying interest coverage of about 6.9x; the corresponding TTM figure is about 6.3x. Debt is not out of control, but this is no longer an “unlevered good company.”

Fact: Another financial feature that must be faced directly is the extremely high share of goodwill and intangible assets in asset quality. At the end of Q1 2026, goodwill was $21.348 billion and other intangible assets were $9.559 billion, for a combined total of about $30.907 billion, close to 89% of total assets of $34.551 billion; tangible book value was negative $12.089 billion in the same period. For value investors, this means your downside protection mainly comes from future cash flow, not liquidation net assets.

Inference: ROE and ROIC must be treated very carefully. Under template definitions, the company’s ROE in recent years is about 8% to 9%, and ROIC about 5% to 6%, which does not look striking; but these figures are diluted by the massive goodwill created through acquisitions. For an acquisition-led platform like Roper, the more meaningful question is not “how high is static consolidated ROIC,” but “can incremental capital deployed into new assets continue to raise free cash flow per share.” Public disclosures can only provide indirect evidence on this question, not a perfect answer.

Owner-earnings analysis Fact: The key 2025 figures are: GAAP net income of $1.536 billion; GAAP operating cash flow of $2.540 billion; company-defined adjusted operating cash flow of $2.570 billion; capital expenditures of $47.4 million; capitalized software expenditures of $57.3 million; company-defined adjusted free cash flow of $2.466 billion. In 2025, there was also about $150 million of one-time cash tax benefit from the repeal of R&D capitalization requirements under U.S. tax law. Management also explicitly stated that this legislation brought about $150 million of cash tax benefit in 2025, with the remaining impact to be realized gradually over the next three to five years.

Assumption: To be as conservative as possible, I look at 2025 “true distributable cash flow” in three layers:

• Broad framework: directly use the company’s 2025 adjusted free cash flow of $2.466 billion.

• Conservative framework: deduct about $150 million of one-time cash tax benefit from $2.466 billion, arriving at about $2.32 billion.

• Middle framework: considering Q1 2026 operating continuity and capitalized software investment, a reasonable annualized owner earnings figure is roughly $2.3 billion to $2.4 billion. This is my estimate, not the company’s official framework.

Inference: At the current share price of about $326.94, and using about 100.92 million shares outstanding as of April 30, 2026, Roper’s current equity market value is about $33.0 billion. Based on my conservative owner earnings estimate of $2.3 billion to $2.4 billion, the current share price implies about 13.7x to 14.3x owner earnings. For a company with highly repeatable revenue, low capital intensity, and long-term capital-allocation capability, this is not expensive; but given the high goodwill share and strong acquisition dependence, it is also not “cigar-butt cheap.”

Valuation and Margin of Safety

The current market price is roughly as follows.

Fact: As of the close on May 22, 2026, Roper’s share price was about $326.94. Using about 100.92 million shares outstanding as of April 30, 2026, equity value is about $33.0 billion. Net debt at the end of Q1 2026 was about $10.081 billion, so enterprise value is roughly $43.1 billion.

Method 1: Owner-earnings DCF Assumption: I use the conservative owner-earnings midpoint from the previous section, $2.25 billion, as the starting point, and value it under three scenarios:

• Conservative scenario: owner earnings grow 3% annually over the next ten years, discount rate 10%, terminal growth 2%.

• Base scenario: annual growth over the next ten years 5%, discount rate 9%, terminal growth 2.5%.

• Optimistic scenario: annual growth over the next ten years 7%, discount rate 8.5%, terminal growth 3%. These assumptions are not aggressive, because they already normalize the one-time tax benefit and do not assume the valuation multiple returns to historical highs. Starting owner earnings and share count come from the company cash flow, repurchase, and current share-price data discussed above.

Opinion: Under these assumptions, my estimated per-share intrinsic value is roughly:

• Conservative intrinsic-value range: $300 to $340;

• Reasonable intrinsic-value range: $360 to $430;

• Optimistic intrinsic-value range: $470 to $560.

This means:

• The current price is roughly in the lower part of my conservative range;

• Relative to the reasonable range, there is a discount of about ten-plus percent to more than twenty percent;

• But because there is no strong asset protection on the downside, I would not call this a “deep margin of safety.” This is model output, not fact. The most fragile parts of the model are long-term growth, acquisition outcomes, and how much capitalized software investment is “growth” rather than “maintenance.”

Method 2: Relative valuation Fact: Under current frameworks, Roper’s main valuation metrics are roughly: PE about 20.3x, P/FCF about 12.9x, EV/EBITDA about 13.4x, and template ROIC about 5.5%. Compared with high-quality peers, Roper’s current valuation is clearly lower: Verisk currently trades at PE 26.2x, P/FCF 19.9x, EV/EBITDA 17.6x, and ROIC 27.8%; Tyler at about 43.3x, 19.2x, 28.4x, and 7.0%; AMETEK at about 33.9x, 30.2x, 22.1x, and 11.1%; FICO at about 39.4x, 31.7x, 27.6x, and 56.0%.

Data note: The table uses current template frameworks from StockAnalysis/Fiscal.ai; Roper’s current price can also be directly verified from market data. Roper and these companies are not one-to-one direct comparables, so this table can only be used as a valuation coordinate for “high-quality compounding assets,” not to mechanically derive a fair multiple.

Opinion: Relative valuation gives a clearer conclusion than DCF: Roper is not expensive today, and is even relatively cheap. The question is whether that cheapness is justified. The market is probably pricing in the following discounts:

• Roper is an acquisition-led platform, and the future depends on capital allocation;

• Leverage is higher than at some pure-software peers;

• Goodwill and intangible assets are very high;

• The 2026 incentive-plan expansion creates potential dilution. So Roper should not simply be benchmarked against FICO or Tyler’s high multiples, but it also should not be treated as a low-quality industrial stock.

Method 3: Asset or liquidation value Fact: Roper is not a company that is suitable for pricing by asset revaluation. At the end of Q1 2026, tangible book value was negative about $12.09 billion; intangible assets and goodwill together totaled about $30.9 billion. In other words, if you want downside protection from “land, inventory, net cash, and fixed assets,” Roper does not fit that type.

Opinion: The asset method is more of a “reverse reminder” here: this is not an investment protected by liquidation value, but by future cash flow. This is also one reason I rate it “Cautious Buy” rather than “Strong Buy.”

On margin of safety My conclusion is: a margin of safety exists, but it is not abundant enough to ignore execution risk.

• If future growth falls short of expectations but owner earnings can still grow around 3%, the current price can roughly still support mid-single-digit to high-single-digit annualized returns.

• If margins slip slightly, the investment logic does not necessarily fail immediately because capital intensity is very low; but if growth slows, acquisitions go wrong, and multiples compress further, returns would be clearly damaged.

• This is a typical situation of “a good company that may still not be cheap enough.” For more conservative investors, I would prefer a buy range of $280 to $320; for long-term investors who already own it or plan to build a position gradually, $320 to $380 can be viewed as an acceptable hold/slow-buy range; if the share price returns to above $450 without a materially stronger business, I would view clear overvaluation risk as having reappeared.

Risks, Comparisons, Checklist, and Final Judgment

Most important risks and counterarguments

Competitive risk Fact: The company itself clearly acknowledges that most product lines face significant competition, although some niche markets have fewer competitors; and no single company competes with it comprehensively across a large number of product lines. For investors, this means “portfolio-level diversification and single-business-level competition” coexist.

Risk of technological substitution and business-model disruption Fact: Roper’s 2025 10-K separately identifies AI risk, including AI-driven attacks, deepfakes, prompt injection, data poisoning, and other new risks. It also notes that the company’s ability to effectively develop, deploy, and use AI in its platforms and products is a key variable. The company believes proprietary data and deep workflows can enhance AI product differentiation; but if general-purpose models erode the value of industry software faster, the moat would weaken.

Regulatory risk Fact: The medical-device business faces FDA and overseas regulation, while software and data businesses face GDPR, CCPA, HIPAA, and other data and privacy requirements. For an increasingly data-driven software-asset portfolio, compliance costs and incident costs could both rise.

Financial leverage risk Fact: At the end of Q1 2026, net debt was about $10.081 billion, and net debt/EBITDA was roughly near 3.1x. Although the company still complies with debt covenants and interest coverage remains acceptable, this leverage is not low for a large acquisition platform. If capital markets, interest rates, or the operating environment deteriorate, debt flexibility would decline.

Valuation and dilution risk Fact: Although current valuation has compressed significantly relative to high-quality peers, in 2026 the company approved proposals to expand the incentive pool and ESPP. The former adds 14.15 million shares, and the latter adds 1.00 million authorized shares. A low historical burn rate does not mean future dilution cannot become stronger.

Cyclicality and demand-volatility risk Fact: In 2024, the company issued a softer outlook because enterprise software spending was weak and contracts were delayed. This shows that even high-quality workflow software can be dragged down by the economic environment. If customers such as universities, schools, hospitals, insurers, construction firms, and logistics participants become more cautious with budgets, Roper may still experience short-term fluctuations in orders and upgrade timing.

Accounting and acquisition risk Fact: Roper’s balance sheet has extremely high goodwill and intangible assets, and the company explicitly warns of potential goodwill and intangible-asset impairment risk. If acquired assets fail to meet expectations, impairment itself does not directly consume cash, but it would expose past capital-allocation mistakes and could trigger a valuation reset.

Strongest bear case If I were to construct the strongest short-side argument, it would probably be this: Roper now looks like a “cheap high-quality compounding platform,” but that cheapness comes precisely from the market’s unwillingness to keep pricing it as a “high-multiple acquisition legend.” Its underlying assets are good, but not all of them have irreplaceable network effects; template ROIC is not high; leverage is elevated; assets provide almost no tangible downside; and future growth depends heavily on continued acquisitions and integration. If acquisition markets become expensive, good targets become scarce, or management starts using a larger incentive pool and repurchases to maintain per-share metrics, Roper could deteriorate from a “compounding platform” into a “slower-growth, high-goodwill portfolio company.” In that case, even if the business remains profitable, shareholders may suffer years of opportunity cost and real capital loss from valuation compression.

Facts that would overturn the investment judgment If any of the following persist, I would acknowledge that my original judgment may be wrong:

• Organic growth remains clearly below low-single digits for multiple consecutive years, while acquisitions maintain only surface-level growth.

• The share of recurring/highly repeatable revenue stops rising and instead declines.

• Operating margin and owner-earnings conversion deteriorate meaningfully.

• Leverage continues to rise while acquisition returns do not improve accordingly.

• A major data-security incident, regulatory penalty, or impairment of acquired assets occurs.

• Equity dilution becomes clearly faster than the historical burn rate, while management still claims “per-share value growth.”

Comparison with other opportunities

Comparison with strongest competitors/alternative investments Opinion: Within “high-quality vertical software/data compounders,” I would rather view Verisk as the strongest alternative reference point, not a direct competitor in the full sense. Verisk is purer and has clearly higher ROIC, but its current valuation remains higher than Roper’s. Tyler is more focused on government software, AMETEK leans more toward high-quality industrial technology, and FICO is a more extreme data and scoring-system business. By comparison, Roper’s advantages are a more diversified portfolio and lower valuation; its drawbacks are greater dependence on management’s acquisition and portfolio-reallocation capability.

Comparison with the S&P 500 Index Opinion: If your goal is simply to earn long-term U.S. large-cap market returns, a low-cost S&P 500 index is simpler, more diversified, and less dependent on judging a single management team. Whether Roper is worth replacing part of an index allocation depends on whether you believe: first, its owner earnings can grow above GDP over the long term; second, management can keep allocating capital at high quality. After the current valuation compression, Roper may be more attractive than many high-quality growth stocks, but it still is not as “management-validation-free” as an index.

Comparison with the risk-free rate Fact + inference: On May 21, 2026, the U.S. 10-year Treasury yield was about 4.57%. Based on my conservative owner-earnings estimate, Roper’s current owner-earnings yield is around 7%, implying a risk premium of roughly 2.5 percentage points over the risk-free rate. This premium is not especially high, but given the company’s quality and medium- to long-term growth potential, it is still reasonable; if you demand an extremely thick margin of safety, the premium is not attractive enough.

If I could hold only five assets, would it qualify for the portfolio? My answer: it qualifies for the candidate list, but it does not automatically deserve a heavy position. If you prefer long-term compounding assets with “high quality, strong cash flow, and management that can allocate capital,” Roper can make the shortlist; if you prefer companies that are “simple, transparent, and asset-protected on the downside,” it may not be top five.

Investment Checklist

Data-support note: The Checklist judgments above are formed by combining the company’s 10-K, 10-Q, proxy materials, company business pages, valuation comparisons, and current market data.

Open questions and limitations Public materials do not sufficiently disclose the long-term return of each large acquisition, and they do not allow a precise split of capitalized software investment between “maintenance” and “growth.” In addition, Roper does not have truly one-to-one direct comparables, so relative valuation can only be an auxiliary tool. In other words, you can compare its quality and cash-flow characteristics, but you cannot mechanically apply a standard pure-software multiple to it.

Final investment conclusion

【Final Rating】 Cautious Buy

【One-sentence investment thesis】 Roper is a compounding platform made up of sticky vertical software and technology niche assets that can generate real cash flow over the long term, while the current price already reflects a meaningful discount for acquisition dependence and complexity.

【Core bullish reasons】

• High software and recurring-revenue mix, strong business stickiness, and good cash-flow visibility.

• Very low capital intensity, with operating cash flow and adjusted free cash flow consistently stronger than net income over the long term.

• Management’s historical capital-allocation direction has been correct, and the portfolio has continued to upgrade toward higher-quality software/data assets.

• Current valuation has compressed meaningfully relative to high-quality peers.

• Recent large-scale repurchases occurred after a clear valuation pullback, suggesting management is not completely ignoring price.

【Core bearish reasons】

• Downside protection mainly comes from future cash flow rather than tangible assets; tangible book value is negative.

• Growth still depends heavily on acquisitions, and public materials cannot prove every deal has generated high returns.

• Net debt is not low; if operations slow, capital-allocation flexibility will decline.

• The latest incentive plan and ESPP authorizations expanded, so future dilution needs watching.

• This company is not “simple” and requires ongoing tracking of multiple businesses and management capital allocation.

【Key assumptions】

• Owner earnings can grow at least in the low- to mid-single digits over the long term.

• Large acquisitions will not materially worsen group returns.

• Deferred revenue, high retention, and workflow stickiness can be maintained.

• Leverage will not move materially beyond the currently manageable zone near roughly 3x EBITDA.

• AI is more likely to strengthen the existing moat than destroy it.

【Ideal/Fair Buy Price】 My preferred buy range is $280 to $320; $320 to $380 is acceptable for gradual position-building or patient holding; if the price returns to above $450 without stronger fundamental improvement, I would treat it as one clearly overvalued zone. The basis is the conservative/base owner-earnings DCF results, the current relative valuation discount, and the lack of strong asset-side downside protection.

【Target holding period】 At least more than five years, and more suitable for more than ten years. This is not a short-term catalyst investment, but a name that needs time for organic business growth, acquisition integration, repurchases, and per-share cash-flow compounding to work.

【Expected annualized return】 This is model inference, not fact:

• Conservative scenario: about 7% to 9%;

• Base scenario: about 10% to 12%;

• Optimistic scenario: about 13% to 15%. This corresponds to a current owner-earnings yield around 7%, plus different growth and terminal-value assumptions.

【Maximum loss risk】 In a normal bad scenario, if the market prices Roper at about 10x to 11x conservative owner earnings, the share price could fall to roughly $230 to $270; in a more extreme scenario, if acquisitions fail, growth slows sharply, impairments occur, and multiples compress, a decline to $180 to $220 is not completely unimaginable. The largest permanent capital loss would not come from short-term volatility, but from a “high-goodwill acquisition platform losing its capital-allocation edge.” This is inference, not prediction.

【Tracking indicators】 Going forward, I will continue to track the share of recurring and highly repeatable revenue, organic growth by segment, operating margin, operating cash flow and adjusted free cash flow, capitalized software expenditures as a share of revenue, net debt/EBITDA, average repurchase price and repurchase scale, valuation and integration progress of major acquisitions, changes in deferred revenue and contract liabilities, equity-incentive burn rate, and total dilution.

【Signals that trigger reassessment】 If any of the following occur, the logic must be reassessed: organic growth remains low for more than two consecutive years; margins or cash-flow conversion deteriorate meaningfully; a major data-security or regulatory event occurs; a large impairment appears after an acquisition; net debt rises materially without stronger cash flow; dilution clearly exceeds the historical burn rate; management begins to emphasize “scale growth” more than “growth in intrinsic value per share.”

【Final recommendation】 If you are a balanced but somewhat conservative investor with a holding period of more than 10 years, I would view Roper as a compounding asset worth close tracking and suitable for gradual accumulation, but not suitable for an impulsive heavy position. It is very likely a good business and probably a good company; but it is not the kind of company one can “buy with eyes closed” without continuous verification. What truly determines your future return is not only how good Roper is today, but whether it can continue to deploy shareholders’ cash into places that are worth more than the cash itself.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.